Kroeger Christopher A. 4
4 · MapLight Therapeutics, Inc. · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
MapLight (MPLT) CEO Christopher Kroeger Sells Shares
What Happened
Christopher A. Kroeger, CEO of MapLight Therapeutics (MPLT), sold a total of 118,235 shares on May 18, 2026. The filing shows two open‑market sales: 118,037 shares at a weighted‑average price of $27.19 for $3,209,426 (transaction price range $26.565–$27.4347) and 198 shares at a weighted‑average price of $28.15 for $5,574 (transaction price range $27.57–$28.20). These were sales (S), not purchases.
Key Details
- Transaction date (and Form 4 filing date): May 18, 2026 (filed same day). Accession: 0001658918-26-000012.
- Shares sold: 118,037 @ $27.19 (WA) = $3,209,426; 198 @ $28.15 (WA) = $5,574. Total shares sold = 118,235; total proceeds = $3,215,000.
- Footnotes: the 118,037‑share sale was made pursuant to a Rule 10b5‑1 trading plan adopted Dec 29, 2025. Both sales report weighted‑average prices and list the per‑share price ranges; the filer offers to provide the breakdown of shares sold at each individual price on request.
- Ownership after transaction: not specified in the data provided here—see the full Form 4 for post‑trade holdings.
- Transaction code: S (sale). Filing appears timely (same‑day).
Context
Insider sales can be routine (e.g., scheduled under a 10b5‑1 plan, tax planning, diversification) and don’t by themselves indicate company performance. The presence of a 10b5‑1 plan for the larger block means at least that portion was pre‑arranged. Purchases tend to be more informative as a bullish signal; this filing documents sales only.
Insider Transaction Report
- Sale
Voting Common Stock
[F1][F2]2026-05-18$27.19/sh−118,037$3,209,426→ 1,394,292 total - Sale
Voting Common Stock
[F1][F3]2026-05-18$28.15/sh−198$5,574→ 1,394,094 total
Footnotes (3)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 29, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.565 to $27.4347 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.57 to $28.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.